Surface Ophthalmics

About:

Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases.

Website: https://surfaceophthalmics.com

Description:

Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases. The company's current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity, a patented delivery vehicle. Surface Ophthalmics was founded in 2017 and is based in Pleasanton, California.

Total Funding Amount:

$40M

Headquarters Location:

Pleasanton, California, United States

Founded Date:

2016-01-01

Founders:

Kamran Hosseini, Mark Baum

Number of Employees:

1-10

Last Funding Date:

2021-06-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai